Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Conditions
Chronic Rhinosinusitis Without Nasal Polyps
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
San Tan Allergy & Asthma, Gilbert, Arizona, United States
Children's Hospital of Orange County, Orange, California, United States
Contact: Principal Investigator (Jay Bhatt, MD)DaVinci Research, LLC, Sacramento, California, United States
Contact: Principal Investigator (Randall Ow, MD)Breathe Clear Institute, Torrance, California, United States
Contact: Principal Investigator (Steven Davis, MD)Children's Hospital Colorado, Aurora, Colorado, United States
Contact: Principal Investigator (Sarah Gitomer, MD)Colorado ENT & Allergy, Colorado Springs, Colorado, United States
Contact: Principal Investigator (Bryan Davis, MD)Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Contact: Principal Investigator (Kenneth Kennedy, MD)Southern Illinois University School of Medicine, Springfield, Illinois, United States
Contact: Principal Investigator (Dana Crosby, MD)Kentuckiana ENT, Louisville, Kentucky, United States
Contact: Principal Investigator (Thomas Higgins, MD)Centers for Advanced ENT Care, Towson, Maryland, United States
Contact: Principal Investigator (Douglas Reh, MD)University of Missouri Medical Center, Columbia, Missouri, United States
Contact: Principal Investigator (Christine Franzese, MD)University of Rochester Medical Center, Rochester, New York, United States
Contact: Principal Investigator (Li-Xing Man, MD)Allergy, Asthma and Clinical Research Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Martha Tarpay, MD)Vital Prospects Clinical Research Institute, Tulsa, Oklahoma, United States
Contact: Principal Investigator (Iftikhar Hussain, MD)Charleston ENT & Allergy, North Charleston, South Carolina, United States
Contact: Principal Investigator (Thomas Murphy, MD)Carolina ENT Clinic/CENTRI Inc., Orangeburg, South Carolina, United States
Contact: Principal Investigator (John Ansley, MD)Orion Clinical Research, Austin, Texas, United States
Contact: Study coordinator (Stephanie Nunnelee) · sfnunnelee@orionclinicalresearch.com · 512-492-3799Contact: Principal Investigator (William Howland, III, MD)STAAMP Research, San Antonio, Texas, United States
Contact: Principal Investigator (Erika Gonzalez, MD)Alamo ENT Associates, San Antonio, Texas, United States
Contact: Principal Investigator (Jeffrey Rosenbloom, MD)University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Jill Jeffe, MD)EVMS at Old Dominion University, Norfolk, Virginia, United States
Contact: Principal Investigator (Kent Lam, MD)
Study leads
Amy Manley
Study Chair
Paratek Pharma